Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2021 01:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech fourth quarter and preliminary full year 2020 results

Oslo (Norway), 24 February 2021 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q4 and preliminary full year 2020 results. Please find enclosed the...
February 18, 2021 03:02 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to fourth quarter 2020 results presentation

Oslo, Norway, 18 February 2021 - PCI Biotech’s (OSE: PCIB) fourth quarter and preliminary full year 2020 interim report will be released on 24 February 2021 at 07.00 CET. The interim report and...
February 10, 2021 02:31 ET | Source: PCI Biotech Holding ASA

PCI Biotech - release of the RNA Therapeutics Virtual Conference presentation

Oslo (Norway), 10 February 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today released...
January 22, 2021 06:04 ET | Source: PCI Biotech Holding ASA

PCI Biotech to present at RNA Therapeutics Virtual Conference

Oslo (Norway), 22 January 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...
November 23, 2020 02:30 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Successful Phase I fimaVacc vaccination proof of concept study to be published in Frontiers in Immunology

Oslo (Norway), 23 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced that the results from the successful Phase I proof of concept study for the...
November 16, 2020 02:30 ET | Source: PCI Biotech Holding ASA

PCI Biotech: European patent for treatment of bile duct cancer with the fimaChem technology

Oslo (Norway), 16 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces that the European Patent Office (EPO) has informed the company that a new...
November 11, 2020 01:00 ET | Source: PCI Biotech Holding ASA

PCI Biotech third quarter 2020 results

Oslo (Norway), 11 November 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announces its interim Q3 2020 results. Please find enclosed the report and presentation. ...
November 04, 2020 03:15 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Invitation to third quarter 2020 results presentation

Oslo, Norway, 4 November 2020 - PCI Biotech’s (OSE: PCIB) third quarter 2020 interim report will be released on 11 November 2020 at 07.00 CET. The interim report and presentation will be made...
October 26, 2020 07:48 ET | Source: PCI Biotech Holding ASA

PCI Biotech: First patient enrolled in Asia in the fimaCHEM pivotal RELEASE study

Oslo (Norway), 26 October 2020 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced...
October 21, 2020 02:30 ET | Source: PCI Biotech Holding ASA

PCI Biotech: Preclinical research collaboration with big pharma ended

Oslo (Norway), 21 October 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today informed that AstraZeneca has elected not to enter into a definitive agreement for the...